Can erythrocyte sedimentation rate (ESR) be low in a patient over 50 with suspected polymyalgia rheumatica (PMR) who is taking prednisolone (corticosteroid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can ESR Be Low in PMR Patients Taking Prednisolone?

Yes, ESR can absolutely be low in a patient with polymyalgia rheumatica who is taking prednisolone, as corticosteroids suppress inflammatory markers including ESR. 1

Understanding the Effect of Prednisolone on ESR

Prednisolone directly suppresses the acute phase response, which means:

  • ESR and CRP levels drop rapidly after initiating corticosteroid therapy, typically within days to weeks 2
  • A normalized ESR during treatment does NOT exclude active PMR and should not be the sole criterion for treatment decisions 3
  • The suppression of inflammatory markers is actually the expected therapeutic response, making ESR less reliable for monitoring disease activity once treatment has started 2

Clinical Implications for Diagnosis and Monitoring

If Prednisolone Was Started Before Diagnosis:

  • This creates a diagnostic dilemma because the dramatic clinical response to steroids that helps confirm PMR has already occurred, and inflammatory markers are now artificially suppressed 1
  • The patient may have PMR but now lacks the typical elevated ESR that would support the diagnosis 4, 5
  • Consider measuring ESR/CRP before any dose changes if diagnostic uncertainty remains 6

If Prednisolone Was Started After Diagnosis:

  • Low ESR during treatment is expected and appropriate - it reflects therapeutic response 2
  • Clinical symptoms should guide management more than ESR values during the treatment phase 1
  • EULAR/ACR guidelines recommend monitoring both ESR and CRP during follow-up, but emphasize that treatment decisions should be based primarily on clinical response, not laboratory values alone 6, 7

Important Caveats

A normalized ESR on prednisolone does not exclude complications:

  • One case report documented biopsy-proven giant cell arteritis developing in a PMR patient whose ESR had normalized on low-dose corticosteroids 3
  • If new symptoms suggestive of giant cell arteritis develop (headache, jaw claudication, visual symptoms), temporal artery biopsy should be performed regardless of ESR values 3

PMR can present with normal ESR even before treatment:

  • Approximately 7-22% of PMR patients have normal or only slightly elevated ESR at diagnosis 4, 5
  • These patients tend to be younger, more often male, and have less constitutional symptoms, but respond equally well to corticosteroids 5
  • EULAR/ACR guidelines classify PMR with normal inflammatory markers as an atypical presentation warranting specialist referral 7, 8

Practical Approach

For monitoring patients already on prednisolone:

  • Base treatment adjustments primarily on clinical symptoms (pain, stiffness, functional status) rather than ESR alone 1
  • Follow-up intervals should be every 4-8 weeks in the first year, every 8-12 weeks in the second year 1
  • ESR may rise again during disease flares or relapses, at which point it regains some monitoring value 7
  • High baseline ESR (>40 mm/1st hour) before treatment predicts higher relapse risk and need for prolonged therapy 1, 6

The key principle: Once prednisolone is started, ESR becomes an unreliable marker because the drug itself suppresses it - clinical assessment becomes paramount 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ESR as a Preferred Marker for Polymyalgia Rheumatica

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Polymyalgia Rheumatica Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for PMR in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.